| Literature DB >> 628744 |
A A Moss, H Y Kressel, M Korobkin, H I Goldberg, B M Rohlfing, R C Brasch.
Abstract
The effect of Gastrografin and glucagon on pancreatic CT scanning was studied in a blind clinical trial. Twenty-five patients had a pancreatic CT scan performed on an 18-second scanner and a repeat pancreatic CT scan following administration of Gastrografin and glucagon. The results were statistically significant: decreased streak artifacts; improved pancreatic head, body and tail delineation; and improved overall pancreatic visualization. Gastrografin-glucagon administration is recommended prior to pancreatic CT scanning if the scanning cycle is 18 seconds or longer.Entities:
Mesh：
Substances：
Year: 1978 PMID： 628744 DOI： 10.1148/126.3.711
Source DB: PubMed Journal: Radiology ISSN： 0033-8419 Impact factor: 11.105